Sort
48,018 grants matching “immunotherapy”
Mechanisms of protection against shigellosis in children
$778,440Marcela F Pasetti · University Of Maryland Baltimore · R01 · FY2022 · AI
Chemoenzymatic glycan editing for deciphering biological functions of glycans
$778,432Peng Wu · Scripps Research Institute, The · R35 · FY2025 · GM
Chemoenzymatic glycan editing for deciphering biological functions of glycans
$778,432Peng Wu · Scripps Research Institute, The · R35 · FY2024 · GM
Molecular Genetic Analysis of Mycobacterium Tuberculosis
$778,383William Robert Jacobs · Albert Einstein College Of Medicine · R37 · FY2025 · AI
Uncovering the Biology of Resistance to Tyrosine Kinase Inhibitors in EGFR Mutant Lung Cancer Patient-Derived Models.
$778,382Katerina Abigail Politi · Yale University · U01 · FY2021 · CA
Enabling immunotherapy for high-risk Group 3 medulloblastoma via systems immunology
$778,050Hongbo Chi · St. Jude Children'S Research Hospital · U01 · FY2024 · CA
CONTROL AND ACTIVATION OF THE TUMOR NECROSIS FACTOR RECEPTORS
$777,979Gerhard Wagner · Harvard Medical School · R01 · FY2023 · AI
Inducing Tolerance with 5-Module chimeric Antigen Receptor (5MCAR) T Cells
$777,783Michael S Kuhns · University Of Arizona · R56 · FY2020 · AI
Senior Leaders
$777,779Judith Cheryl Gasson · University Of California Los Angeles · P30 · FY2010 · CA
Personalized neuroblastoma vaccines
$777,310John M Maris · Children'S Hosp Of Philadelphia · U01 · FY2024 · CA
GM/CSF FUSION PROTEINS &DENDRITIC CELLS AS TUMOR VACCIN
$777,182Stanford University · U19 · FY2000 · CA
Mechanisms of Chronic Hepatitis B Infection and Therapeutic Vaccines
$777,154David R. Milich · Vaccine Research Institute Of San Diego · R01 · FY2011 · AI
Preclinical toxicology and pharmacology evaluation of a newTNFR2 antagonistic monoclonal antibody for CTCL therapy
$776,973Kenneth Olivier · Boston Immune Technologies And Therapeutics, Inc. · R44 · FY2024 · CA
FOXP3 ÎE2 isoform in asthma severity and persistence
$776,962Baohua Zhou · Indiana University Indianapolis · R01 · FY2025 · AI
FOXP3 ÎE2 isoform in asthma severity and persistence
$776,962Baohua Zhou · Indiana University Indianapolis · R01 · FY2024 · AI
Targeting the immunosuppressive tumor microenvironment to enhance efficacy of radiotherapy and immuno-radiotherapy for oral cancer
$776,961Andrew Sikora · Baylor College Of Medicine · U01 · FY2019 · DE
Engineering T cells to Promote Islet Transplant
$776,922James L Riley · University Of Pennsylvania · R01 · FY2023 · DK
COOPERATIVE HUMORAL &CELLULAR IMMUNITY AGAINST HIV/SIV
$776,662Scripps Research Institute · R01 · FY2004 · AI
CD137 AS A TARGET FOR THE IMMUNOTHERAPY OF CANCER
$776,587Daniel G. Schindler · Gtc Biotherapeutics, Inc. · R44 · FY2006 · CA
Perivascular Inflammation and Vascular Remodeling: A Common Cause of Hemorrhage in Cerebral Small Vessel Diseases?
$776,503Susanne Janneke Van Veluw · Massachusetts General Hospital · R56 · FY2023 · NS
Endothelial Injury, BMPR2 Dysfunction and Macrophage Activation Cause EndMT and PAH
$776,362Marlene Rabinovitch · Stanford University · R01 · FY2017 · HL
Delaware Christiana Care CCOP
$776,359Christiana Care Health Services, Inc. · U10 · FY2003 · CA
National Gnotobiotic Resource Center
$776,328Ryan Balfour Sartor · Univ Of North Carolina Chapel Hill · P40 · FY2024 · OD
National Gnotobiotic Resource Center
$776,328Ryan Balfour Sartor · Univ Of North Carolina Chapel Hill · P40 · FY2025 · OD
Regulation and Function of WIP1 Phosphatase and its Role in Tumor Cells
$776,295Ettore Appella · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA